Trupanion (NASDAQ:TRUP) Stock Price Down 2.2%

Trupanion, Inc. (NASDAQ:TRUPGet Free Report) shares traded down 2.2% during mid-day trading on Wednesday . The company traded as low as $21.69 and last traded at $21.69. 29,356 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 670,590 shares. The stock had previously closed at $22.17.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the stock. Piper Sandler dropped their price objective on shares of Trupanion from $32.00 to $28.00 and set a “neutral” rating for the company in a report on Friday, April 5th. Evercore ISI reduced their price target on shares of Trupanion from $35.00 to $31.00 and set an “outperform” rating on the stock in a research report on Tuesday, February 20th. Finally, Stifel Nicolaus increased their price target on shares of Trupanion from $25.00 to $28.00 and gave the stock a “hold” rating in a research report on Friday, February 16th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat, Trupanion currently has a consensus rating of “Hold” and an average target price of $33.20.

Read Our Latest Research Report on Trupanion

Trupanion Stock Performance

The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The business’s fifty day simple moving average is $26.62 and its two-hundred day simple moving average is $26.96.

Trupanion (NASDAQ:TRUPGet Free Report) last announced its earnings results on Thursday, February 15th. The financial services provider reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.18) by $0.13. The business had revenue of $295.50 million for the quarter, compared to analyst estimates of $289.84 million. Trupanion had a negative net margin of 4.03% and a negative return on equity of 15.19%. The company’s revenue for the quarter was up 20.1% compared to the same quarter last year. During the same period last year, the firm posted ($0.23) earnings per share. As a group, analysts predict that Trupanion, Inc. will post -0.43 earnings per share for the current year.

Hedge Funds Weigh In On Trupanion

A number of hedge funds and other institutional investors have recently bought and sold shares of TRUP. BluePath Capital Management LLC purchased a new position in Trupanion in the 3rd quarter valued at $31,000. Belpointe Asset Management LLC lifted its holdings in Trupanion by 2,500.0% in the first quarter. Belpointe Asset Management LLC now owns 832 shares of the financial services provider’s stock valued at $36,000 after acquiring an additional 800 shares during the period. PNC Financial Services Group Inc. lifted its holdings in Trupanion by 61.3% in the second quarter. PNC Financial Services Group Inc. now owns 2,057 shares of the financial services provider’s stock valued at $40,000 after acquiring an additional 782 shares during the period. Tower Research Capital LLC TRC lifted its holdings in Trupanion by 128.4% in the first quarter. Tower Research Capital LLC TRC now owns 1,039 shares of the financial services provider’s stock valued at $45,000 after acquiring an additional 584 shares during the period. Finally, Russell Investments Group Ltd. lifted its holdings in Trupanion by 8,339.4% in the second quarter. Russell Investments Group Ltd. now owns 2,785 shares of the financial services provider’s stock valued at $55,000 after acquiring an additional 2,752 shares during the period.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Stories

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.